FR14C0006I2 - Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes - Google Patents

Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes

Info

Publication number
FR14C0006I2
FR14C0006I2 FR14C0006C FR14C0006C FR14C0006I2 FR 14C0006 I2 FR14C0006 I2 FR 14C0006I2 FR 14C0006 C FR14C0006 C FR 14C0006C FR 14C0006 C FR14C0006 C FR 14C0006C FR 14C0006 I2 FR14C0006 I2 FR 14C0006I2
Authority
FR
France
Prior art keywords
glycopegylation
proteins
methods
peptides produced
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR14C0006C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ratiopharm GmbH
Original Assignee
Ratiopharm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/411,037 external-priority patent/US7125843B2/en
Priority claimed from US10/411,043 external-priority patent/US7439043B2/en
Priority claimed from US10/411,012 external-priority patent/US7265084B2/en
Priority claimed from US10/410,962 external-priority patent/US7173003B2/en
Priority claimed from US10/410,997 external-priority patent/US7157277B2/en
Priority claimed from US10/411,026 external-priority patent/US7795210B2/en
Priority claimed from US10/410,913 external-priority patent/US7265085B2/en
Priority claimed from US10/411,049 external-priority patent/US7297511B2/en
Priority claimed from US10/410,897 external-priority patent/US7179617B2/en
Priority claimed from US10/410,945 external-priority patent/US7214660B2/en
Priority claimed from US10/410,980 external-priority patent/US7399613B2/en
Priority claimed from US10/411,044 external-priority patent/US8008252B2/en
Priority claimed from US10/410,930 external-priority patent/US7226903B2/en
Priority claimed from PCT/US2004/011494 external-priority patent/WO2004099231A2/en
Application filed by Ratiopharm GmbH filed Critical Ratiopharm GmbH
Publication of FR14C0006I1 publication Critical patent/FR14C0006I1/fr
Application granted granted Critical
Publication of FR14C0006I2 publication Critical patent/FR14C0006I2/fr
Active legal-status Critical Current

Links

FR14C0006C 2003-04-09 2014-01-24 Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes Active FR14C0006I2 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US10/410,997 US7157277B2 (en) 2001-11-28 2003-04-09 Factor VIII remodeling and glycoconjugation of Factor VIII
US10/411,026 US7795210B2 (en) 2001-10-10 2003-04-09 Protein remodeling methods and proteins/peptides produced by the methods
US10/410,913 US7265085B2 (en) 2001-10-10 2003-04-09 Glycoconjugation methods and proteins/peptides produced by the methods
US10/411,049 US7297511B2 (en) 2001-10-10 2003-04-09 Interferon alpha: remodeling and glycoconjugation of interferon alpha
US10/411,037 US7125843B2 (en) 2001-10-19 2003-04-09 Glycoconjugates including more than one peptide
US10/411,012 US7265084B2 (en) 2001-10-10 2003-04-09 Glycopegylation methods and proteins/peptides produced by the methods
US10/411,044 US8008252B2 (en) 2001-10-10 2003-04-09 Factor VII: remodeling and glycoconjugation of Factor VII
US10/410,980 US7399613B2 (en) 2001-10-10 2003-04-09 Sialic acid nucleotide sugars
US10/410,930 US7226903B2 (en) 2001-10-10 2003-04-09 Interferon beta: remodeling and glycoconjugation of interferon beta
US10/411,043 US7439043B2 (en) 2001-10-10 2003-04-09 Galactosyl nucleotide sugars
US10/410,945 US7214660B2 (en) 2001-10-10 2003-04-09 Erythropoietin: remodeling and glycoconjugation of erythropoietin
US10/410,897 US7179617B2 (en) 2001-10-10 2003-04-09 Factor IX: remolding and glycoconjugation of Factor IX
US10/410,962 US7173003B2 (en) 2001-10-10 2003-04-09 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
PCT/US2004/011494 WO2004099231A2 (en) 2003-04-09 2004-04-09 Glycopegylation methods and proteins/peptides produced by the methods

Publications (2)

Publication Number Publication Date
FR14C0006I1 FR14C0006I1 (sl) 2014-02-28
FR14C0006I2 true FR14C0006I2 (fr) 2015-01-02

Family

ID=44741018

Family Applications (1)

Application Number Title Priority Date Filing Date
FR14C0006C Active FR14C0006I2 (fr) 2003-04-09 2014-01-24 Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes

Country Status (6)

Country Link
AT (1) ATE525906T1 (sl)
DK (1) DK1615945T3 (sl)
ES (1) ES2373708T3 (sl)
FR (1) FR14C0006I2 (sl)
PT (1) PT1615945E (sl)
SI (1) SI1615945T1 (sl)

Also Published As

Publication number Publication date
DK1615945T3 (da) 2011-12-12
ES2373708T3 (es) 2012-02-08
SI1615945T1 (sl) 2012-03-30
PT1615945E (pt) 2011-12-21
ATE525906T1 (de) 2011-10-15
FR14C0006I1 (sl) 2014-02-28

Similar Documents

Publication Publication Date Title
NO20035010D0 (no) Fremgangsmåter og blandinger for analysering av proteiner
ATE480567T1 (de) Hochkonzentrierter antikörper und proteinformulierungen
DK1663298T3 (da) Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner
DK1680443T3 (da) Stabiliserede alfa-helix-peptider og anvendelser heraf
DK1877090T3 (da) Trimert ox40-immunoglobulin-fusionsprotein og fremgangsmåder til anvendelse heraf
DK1844074T3 (da) Humane antistoffer og proteiner
IL181779A (en) A group of protein-based medical molecules
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
EP1986674A4 (en) PROTEIN OR PEPTIDE COMPOSITIONS PROTEIN CONTAINING METHIONINE AND METHOD FOR MANUFACTURING AND USING SAME
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DK1737961T3 (da) Modificerede bouganin proteiner, cytotoxiner og fremgangsmåder og anvendelser deraf
DK1874557T3 (da) Identitetsdokument og fremgangsmåde til fremstilling deraf
PL1596192T3 (pl) Sposób rozdzielania białek za pomocą elektroforezy kapilarnej i kompozycje buforowe do elektroforezy kapilarnej
DE60335733D1 (de) Verfahren zur solubilisierung von protein
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
DK1523243T3 (da) Mælkeproteinisolat og metode til fremstilling af samme
DK1670823T3 (da) Kimært mhc-protein og oligomer deraf til specifik målretning
DK2371847T3 (da) Peptider og deres afledte type APL af HSP60 og farmaceutiske sammensætninger
IS2894B (is) Framleiðsla sómatóstatínpeptíða
DK1527690T3 (da) Fremgangsmåde til dearomatisering af valleprotein
EP1696943A4 (en) PEPTIDES DIASTEREOMERS USEFUL AS INHIBITORS OF MEMBRANE PROTEIN ASSEMBLY
DE602004013557D1 (de) FLÜSSIGE FORMULIERUNGEN DES TUMORNEKROSEFRAKTOR-BINDUNGSPROTEINs TBP-1
DK1577320T3 (da) Peptider afledt fra humant BPLP-protein, polynukleotider kodende for nævnte peptider og antistoffer rettet mod nævnte peptider
FR14C0006I2 (fr) Methode de glycopegylation et proteines/peptides produits au moyen de ces methodes